Navigation Links
International research group recognizes UTMB experts
Date:4/15/2014

ruses such as Ebola and Marburg, taken at the cellular level using electron microscopy.

Ksiazek is director of high containment operations for the Galveston National Laboratory. He also directs the National Biodefense Training Center, which provides researchers in the United States and around the world with the skills necessary to work safely with deadly pathogens in high-containment laboratories.

Before he came to UTMB in 2008, he was chief of the Special Pathogens Branch at the CDC, where he coordinated outbreak and control responses to especially dangerous pathogens such as Ebola, Marburg, Rift Valley fever, Nipah and SARS viruses. Ksiazek has been extensively involved for decades in outbreak response and pathogen discovery such as the reemergence of H1N1 in 1977 in Asia and the Hantavirus Pulmonary syndrome and Sin Nombre virus in 1993 in the U.S. Southwest, for which he received a national service award for his work from the U.S. Department of Health and Human Services. He is also co-discoverer of the SARS virus.

The International Symposium on Filoviruses began in 2000 and periodically brings together experts from around the world to discuss advances in the diagnosis, treatment, prevention and control of Ebola and Marburg viruses. Filoviruses are transmitted by close contact between infected patients and caregivers. Often starting in rural hospitals or clinics, health care workers are frequently the ones at greatest risk of infection, and many doctors and nurses treating these patients have themselves succumbed to these deadly viruses. Outbreaks are controlled through strict isolation of patients. There is no effective treatment or vaccine to prevent infection.

However UTMB researchers are working to develop and test new vaccines and broad spectrum treatments of these highly lethal hemorrhagic fever viruses. Thomas Geisbert, a professor in UTMB's Department of Microbiology and Immunology and a member of the Institute for
'/>"/>

Contact: Maureen Balleza
maballez@utmb.edu
409-772-8785
University of Texas Medical Branch at Galveston
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. MARC travel awards for the CYTO 2014/International Society for Advancement of Cytometry Meeting
2. The 2nd International Symposium on Transformative Bio-Molecules 2014
3. International consortium discovers 2 genes that modulate risk of breast and ovarian cancer
4. New international partnership aims to unlock wheats potential
5. Wheat stem sawfly devastations lead to another international conference at Montana State University
6. First International Agroforestry Congress in the Philippines
7. EU could afford to lead international climate action
8. Microbe growth to be examined at International Space Station for UC Davis research project
9. Western University primatologist teams with international group to save lemurs
10. ASU professor Lawrence Krauss is elected to the International Academy of Humanists
11. Forests as Capital: International Society of Tropical Foresters Annual Conference in New Haven
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2015)... BEACH GARDENS, Fla. , June 23, ... multi-factor identity management and authentication solutions, today announced ... Altus strong, multi-factor authentication solution.  The enhancements ... of use of the DigitalPersona Altus platform ... biometric reader compatibility. In today,s ...
(Date:6/18/2015)... June 18, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market announces that its Wocket® ... on "Money on the Mark", scheduled to air on WABC ... June 20 th . The broadcast air- ... 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO Gino Pereira ...
(Date:6/17/2015)... Germany , June 17, 2015 ... QIA) today launched new Investigator ® STR assay kits ... the United States . The new genetic fingerprint ... genomic markers (short tandem repeats or STRs) for DNA matching. ... the quality of DNA in each sample, a novel QIAGEN ...
Breaking Biology News(10 mins):Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
... open farmland, wooded "shade" plantations that produce coffee and chocolate ... study says forests remain the best habitat for tropical birds. ... and "agroforests" where crops are grown under trees ... of various types of birds may hurt "ecosystem services" that ...
... estimates, a third of Earth,s organisms live in our planet,s ... mystery. This week, the work of microbiologist James Holden ... into this dark world. In the journal Proceedings ... the first detailed data on methane-exhaling microbes that live deep ...
... of Nursing,s (NYUCN) Joyce K. Anastasi, PhD, DrNP, FAAN, ... of the Division of Special Studies in Symptom Management ... National Institutes of Health (NIH) grant for the study ... The primary aim of the study ...
Cached Biology News:Birds do better in 'agroforests' than on farms 2Birds do better in 'agroforests' than on farms 3Birds do better in 'agroforests' than on farms 4Birds do better in 'agroforests' than on farms 5Scientists define new limits of microbial life in undersea volcanoes 2Scientists define new limits of microbial life in undersea volcanoes 3NYU College of Nursing's Dr. Anastasi awarded $2.5 million from NIH to study IBS symptom management 2
(Date:7/6/2015)... ANGELES , July 6, 2015 ImmunoCellular ... establishment of an agreement with Novella Clinical ... ICT-107 in patients with newly diagnosed glioblastoma. Novella is ... trial services to small to mid-sized oncology companies. The ... sites in the US, Europe ...
(Date:7/3/2015)... , July 3, 2015 /PRNewswire/ ... hakea verkossa osoitteessa  http://www.openinnovationinscience.at ... Innovation in Science" -jatkokoulutusohjelmaan 22.7.2015 ... Gesellschaftin (LBG) tekemän, kansainvälisiä tutkijoita ... terveystieteiden kaksi suurinta haastetta ovat ...
(Date:7/3/2015)... 3, 2015 Forskare ... 2015 på  http://www.openinnovationinscience.at till det återkommande ... som hålls i Wien ... med internationella forskare och vetenskapsmän som genomfördes ... två största utmaningar bristen på incitament för ...
(Date:7/3/2015)... , July 3, 2015 ... 22. september 2015 på  http://www.openinnovationinscience.at om ... der finder sted i Wien ... undersøgelse af internationale forskere og videnskabsmænd foretaget ... to største udfordringer for sundhedsvidenskaben manglen på ...
Breaking Biology Technology:ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 3
... so-called quantum point contact (QPC). This is a narrow ... a 70-nanometer narrow channel, about as wide as the ... that only one electron at a time will fit ... the electric current. As described in the current publication, ...
... Technologies, LLC has been awarded a Phase I Small ... National Institute on Aging. The project is focused on ... tissue (fat) that are regulated by a calorie ... Operations at LifeGen, the technology developed under the ...
... ST. LOUIS, Oct. 21 HIGHLIGHTS:   ... in 2009) Q3 2010 reported sales increased ... sales grew organically by 7%.  Reported sales growth for SAFC (Fine ... growth for SAFC and Research Products increased 14% and 5%, respectively. ...
Cached Biology Technology:LifeGen Technologies Awarded NIH Grant to Identify Biomarkers of a Calorie Restricted Diet in Adipose Tissue 2Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 - 2Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 - 3Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 - 4Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 - 5Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 - 6Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 - 7Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 - 8Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 - 9Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 - 10Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 - 11Sigma-Aldrich (Nasdaq: SIAL) Reports Q3 2010 Diluted EPS of $0.76. Diluted EPS Increased by 9% and 19% on a Reported and Adjusted Basis, Respectively. Q3 Sales Performance Remains Strong; Full Year 2010 Diluted Adjusted EPS Outlook Raised to $3.20 - 12
Quinolinate phosphoribosyltransferase...
ICC Diluent Buffer 250 ml...
This antibody is specific for human J-chain as defined by ELISA assay using purified human immunoglobulin fragments as solid phase target antigen....
...
Biology Products: